TY - JOUR
T1 - Laparoscopic sleeve gastrectomy outcomes in patients with polycystic ovary syndrome
AU - Yheulon, Christopher G.
AU - Millard, Anthony J.
AU - Balla, Fadi M.
AU - Jonsson, Arinbjorn
AU - Constantin, Tinav
AU - Singh, Arvinpal
AU - Srinivasan, Jahnavi
AU - Stetler, Jamil
AU - Patel, Ankit
AU - Lin, Edward
AU - Scott Davis, S.
N1 - Publisher Copyright:
© 2019 Southeastern Surgical Congress. All rights reserved.
PY - 2019/3
Y1 - 2019/3
N2 - Polycystic ovary syndrome (PCOS) is a common disease among the bariatric population. However, there are limited data regarding the impact of laparoscopic sleeve gastrectomy (SG) on these patients. The study was conducted at University Hospital, United States. The purpose of this study was to examine per cent excess body weight loss (%EWL) and diabetes control in patients who have PCOS compared with those without PCOS. A total of 550 female patients underwent SG between December 2011 and October 2016. Retrospective analysis was completed to include follow-up data at 1, 3, 6, and 12 months and yearly after that. Outcomes measured were %EWL and hemoglobin A1c (HgbA1c). The mean and median follow-up for the entire cohort was 21 and 15 months, respectively. Seventy-eight per cent of patients completed at least 12 months of followup for %EWL, although only 21 per cent had similar follow-up for HgbA1c. PCOS patients had similar age (36.3 vs 36.2 years, P 5 0.90), preoperative BMI (47.2 vs 47.2, P 5 0.99), preoperative HgbA1c (6% vs 5.8%, P 5 0.31), conversion rate to gastric bypass, and other associated comorbidities compared with non-PCOS comparisons. There was no difference in %EWL at 12-month (49.7% vs 53.1%, P 5 0.53) or 24-month (43% vs 49.8%, P 5 0.46) postoperative intervals. There was no difference in absolute change of HgbA1c at 12 months (20.47% vs 20.67%, P 5 0.39). SG has equivalent short-term results in %EWL and reduction in HgbA1c for patients who have PCOS and those who do not.
AB - Polycystic ovary syndrome (PCOS) is a common disease among the bariatric population. However, there are limited data regarding the impact of laparoscopic sleeve gastrectomy (SG) on these patients. The study was conducted at University Hospital, United States. The purpose of this study was to examine per cent excess body weight loss (%EWL) and diabetes control in patients who have PCOS compared with those without PCOS. A total of 550 female patients underwent SG between December 2011 and October 2016. Retrospective analysis was completed to include follow-up data at 1, 3, 6, and 12 months and yearly after that. Outcomes measured were %EWL and hemoglobin A1c (HgbA1c). The mean and median follow-up for the entire cohort was 21 and 15 months, respectively. Seventy-eight per cent of patients completed at least 12 months of followup for %EWL, although only 21 per cent had similar follow-up for HgbA1c. PCOS patients had similar age (36.3 vs 36.2 years, P 5 0.90), preoperative BMI (47.2 vs 47.2, P 5 0.99), preoperative HgbA1c (6% vs 5.8%, P 5 0.31), conversion rate to gastric bypass, and other associated comorbidities compared with non-PCOS comparisons. There was no difference in %EWL at 12-month (49.7% vs 53.1%, P 5 0.53) or 24-month (43% vs 49.8%, P 5 0.46) postoperative intervals. There was no difference in absolute change of HgbA1c at 12 months (20.47% vs 20.67%, P 5 0.39). SG has equivalent short-term results in %EWL and reduction in HgbA1c for patients who have PCOS and those who do not.
UR - http://www.scopus.com/inward/record.url?scp=85064314062&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064314062&partnerID=8YFLogxK
M3 - Article
C2 - 30947769
AN - SCOPUS:85064314062
SN - 0003-1348
VL - 85
SP - 252
EP - 255
JO - American Surgeon
JF - American Surgeon
IS - 3
ER -